Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexamethasone in Traumatic Brain Injury
NCT05323149Phase 3Recruiting
- Sponsor
- Assiut University
- Start
- May 2022
- Primary completion
- Sep 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of dexamethasone in traumatic brain injury (TBI) (2 arms), sponsored by Assiut University. Primary endpoint: Percentage of patients with decreased inflammatory response at 48 hours. Started May 2022; status: recruiting.
02
Drugs
dexamethasone
03
Conditions
traumatic brain injury (TBI)
Beyond the preview
Go deeper on NCT05323149.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05323149.